Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DN0A1J
|
|||
| Drug Name |
MIB-626
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 1/2 | [1] | |
| Company |
Brigham and Women's Hospital
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05040321) A Proof of Concept Trial of a Sirtuin-NAD Activator in Alzheimer's Disease. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.